⨯

  • 07 Dec 22

EKF Diagnostics (EKF) - Q&A with Harwood Capital CEO, Christopher Mills

EKF Diagnostics (EKF) - Q&A with Harwood Capital CEO, Christopher Mills

EKF Diagnostics Holdings plc | EKDHF | 0 -0.75 (0.0%)

    • 19 views

 

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via the share buttons below. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

EKF Diagnostics (EKF) - Vox Markets Fund Manager Series: Christopher Mills, CEO of Harwood Capital

Companies: EKF Diagnostics Holdings plc

NetScientific "well positioned for growth" when venture capital market turns

Companies: NetScientific plc

EKF Diagnostics (EKF) - Vox Markets Fund Manager Series: Judith MacKenzie of Downing Asset Management

Companies: EKF Diagnostics Holdings plc

Tissue Regenix Group says "disciplined approach" paying off at half-year stage

Companies: Tissue Regenix Group plc

EKF Diagnostics (EKF) - Vox Markets Fund Manager Series: Brendan Gulston of Gresham House

Companies: EKF Diagnostics Holdings plc

Creo Medical – executive interview with Craig Gulliford, CEO

Companies: Creo Medical Group Plc

Copyright © 2023 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top